Inventor · disambiguated record
Anthony B. Nesburn
Also filed as: NESBURN ANTHONY · NESBURN ANTHONY B · NESBURN ANTHONY BART
19 granted patents·6 pending applications·880 citations·filing 1988–2014
96Inventor score
Files withCEDARS SINAI MEDICAL CENTER12ISTA PHARMACEUTICALS INC4UNIV CALIFORNIA3ADVANCED CORNEAL SYSTEMS2ADVANCED CORNEAL SYSTEMS INC1
Top patents by PatentIndex Score
25 records- 0194US6537545B1Use of corneal hardening agents in enzymeorthokeratologyISTA PHARMACEUTICALS INC·Filed 2000·Granted Mar 25, 2003·108 cites·8 claims
- 0289US5866120AMethod for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidaseADVANCED CORNEAL SYSTEMS INC·Filed 1995·Granted Feb 2, 1999·76 cites·9 claims
- 0389US5679348AImmunotherapy for recurrent HSV infectionsCEDARS SINAI MEDICAL CENTER·Filed 1992·Granted Oct 21, 1997·87 cites·6 claims
- 0488US5660692AMethod of crosslinking amino acid-containing polymers using photoactivatable chemical crosslinkersCEDARS SINAI MEDICAL CENTER·Filed 1995·Granted Aug 26, 1997·83 cites·26 claims
- 0587US6863886B2Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disordersADVANCED CORNEAL SYSTEMS·Filed 2003·Granted Mar 8, 2005·29 cites·20 claims
- 0687US5955088APharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteinsCEDARS SINAI MEDICAL CENTER·Filed 1995·Granted Sep 21, 1999·96 cites·12 claims
- 0784US6838279B2Herpes simplex virus type 1 (HSV-1)-derived vector for selectively inhibiting malignant cells and for expressing desired traits in malignant and non-malignant mammalian cellsCEDARS SINAI MEDICAL CENTER·Filed 2001·Granted Jan 4, 2005·10 cites·4 claims
- 0882US6939542B2Hyaluronidase preparation for ophthalmic administration and enzymatic methods for accelerating clearance of hemorrhagic blood from the vitreous body of the eyeISTA PHARMACEUTICALS INC·Filed 2003·Granted Sep 6, 2005·12 cites·18 claims
- 0982US6551590B2Hyaluronidase preparation for ophthalmic administration and enzymatic methods for accelerating clearance of hemorrhagic blood from the vireous body of the eyeISTA PHARMACEUTICALS INC·Filed 1999·Granted Apr 22, 2003·40 cites·17 claims
- 1081US6610292B2Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disordersISTA PHARMACEUTICALS INC·Filed 1999·Granted Aug 26, 2003·54 cites·19 claims
- 1181US5024742AMethod of crosslinking amino acid containing polymers using photoactivatable chemical crosslinkersCEDARS SINAI MEDICAL CENTER·Filed 1988·Granted Jun 18, 1991·100 cites·21 claims
- 1278US6039943AMethod for accelerating clearance of hemorrhagic blood from the vitreous body with hyaluronidaseADVANCED CORNEAL SYSTEMS·Filed 1998·Granted Mar 21, 2000·33 cites·17 claims
- 1369US6193984B1Pharmaceutical composition of herpes simplex virus typ-1 (HSV-1) glycoproteinsCEDARS SINAI MEDICAL CENTER·Filed 1999·Granted Feb 27, 2001·36 cites·8 claims
- 1468US6774119B1Herpes simplex virus type 1 (hsv-1)-derived vector for selectively inhibiting malignant cells and methods for its use to treat cancers and to express desired traits in malignant and non-malignant mammalian cellsCEDARS SINAI MEDICAL CENTER·Filed 1999·Granted Aug 10, 2004·21 cites·102 claims
- 1563US2006034822A1Hyaluronidase preparation for ophthalmic administration and enzymatic methods for accelerating clearance of hemorrhagic blood from the vitreous body of the eyeKARAGEOZIAN HAMPAR L·Filed 2005·Application pending·0 cites
- 1663US2005069531A1Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disordersFiled 2004·Application pending·0 cites
- 1756US5632992AProcess for the expression of herpes simplex virus type 1 glycoprotein E and method of useCEDARS SINAI MEDICAL CENTER·Filed 1994·Granted May 27, 1997·21 cites·21 claims
- 1854US5294314AMethod of crosslinking amino acid containing polymers using photoactivatable chemical crosslinkersCEDARS SINAI MEDICAL CENTER·Filed 1991·Granted Mar 15, 1994·31 cites·3 claims
- 1953US9878033B2Immunogenic peptides for treatment of herpes simplex virus infection and conditionsUNIV CALIFORNIA·Filed 2014·Granted Jan 30, 2018·0 cites·11 claims
- 2052US5431790AMethod of crosslinking amino acid containing polymers using photoactivatable chemical crosslinkersCEDARS SINAI MEDICAL CENTER·Filed 1993·Granted Jul 11, 1995·42 cites·20 claims
- 2151US2006280752A1Peptide epitope-based vaccine for treating Herpes Simplex Virus infections and related diseasesUNIV CALIFORNIA·Filed 2005·Application pending·0 cites
- 2249US2003219448A1Peptide epitope-based vaccine for treating herpes simplex virus infections and related diseasesCEDARS SINAI MEDICAL CENTER·Filed 2002·Application pending·0 cites
- 2348US2008299140A1Immunogenic Composition and Peptide Sequences for Prevention and Treatment of an Hsv ConditionUNIV CALIFORNIA·Filed 2003·Application pending·0 cites
- 2445US2003175259A1Use of corneal hardening agents in enzymeorthokeratologyFiled 2002·Application pending·0 cites
- 2529US5672349AProcess for the expression of herpes simplex virus type 1 glycoprotein I and methods of useCEDARS SINAI MEDICAL CENTER·Filed 1994·Granted Sep 30, 1997·1 cites·21 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →